New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

When treating a low-lying and bulky cT2N0 rectal adenocarcinoma invading the anal sphincter muscles with neoadjuvant chemoRT for downstaging, would you electively include the inguinal lymph nodes?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

Based on the paper that we published at MDAnderson in 1990, the inguinal recurrence rate is 2 to 5% if they are not treated electively in patients with tumors involving the anal canal. If the tumor is within 2 cm of the anal verge or right at the dentate line, it was 5%. If the tumor was between two...

When would you offer post-operative concurrent chemoradiation in anaplastic thyroid cancer?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

The management of ATC has evolved considerably over recent years with the most significant being a dichotomy of management based on Braf mutation. We typically offer postoperative XRT, including in patients with either a limited or stable DM disease. However, in a multidisciplinary setting, there so...

Would you consider using LDRT for joint pain/arthritis caused by aromatase inhibitors as a means to keep patients on therapy?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

I would try this. I think there is an inflammatory component to this, and the subjective complaints appear to mimic OA. However, I do think this would be a wonderful group of patients to try this on. They are probably already comfortable with radiation, the achiness/discomfort from ET is real and we...

What target volumes do you use for rectosigmoid/very superior rectal cancers?

7
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina at Chapel Hill

The simple answer is that there should be a major alteration in treatment volumes in these patients, as there should be NO target volume as most of these patients with very high rectal/rectosigmoid tumors do not need to be irradiated at all. If one looks at failure patterns, the risk of local failur...

In what situations would you treat a rectal mass as cancer despite negative biopsies?

2
4 Answers

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

It is not uncommon to see a patient with rectal mass highly suspicious for malignancy by endoscopic evaluation but has a negative biopsy. Usually, this is due to superficial biopsy specimens. In our clinic, we usually get repeated endoscopic evaluation with biopsy as our first step. However, a small...

What dose constraints do you use for RCC/Kidney SBRT?

6
3 Answers

Mednet Member
Mednet Member
Radiation Oncology

As is often the case, there is no single answer to this question, and the ALARA principle should always be kept in mind. A good starting place to determine your OAR constraints for a given case is to consider the clinical context. Ultimately, in deciding on allowable OAR constraints, one has to cons...

How do you manage rectal wall infiltration during a rectal spacer procedure?

10
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · The Oregon Clinic-Radiation Oncology West

At ASTRO 2023, PACE-B reported RTOG grade 2+ GI toxicity was exceedingly low at only 1/348 for 78 Gy/39 fx or 62 Gy/20 fx and only 1/363 for 36.25/5 fx. Anyone know what % of patients in PACE-B had SpaceOAR or similar products? This raises the question of whether SpaceOAR or similar products are nee...

Is there any threshold regarding extraprostatic extension to contraindicate a rectal spacer?

7
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Utah School of Medicine

This is an important question, and as far as I know there are no data to guide a response. I personally believe that EPE (within reason) is not a contraindication to hydrogel. One would expect the extension, capsule and prostate to lift in unison, depending on where the extension is. The NCCN guidel...

How would you manage a high grade acinic cell carcinoma of the parotid with isolated recurrence in the ipsilateral neck s/p salvage resection?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Wake Forest School of Medicine

For this patient with a neck recurrence and (presumably) no evidence of primary site recurrence who had been treated with RT previously to the parotid bed, I would treat ipsilateral neck levels IB, II, III, IV, and V. While IB coverage may be controversial, if the recurrence was in level II, I would...

What are the indications for adjuvant radiation for a resected acinic carcinoma of the parotid?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Although considered low risk, acinic cell carcinoma may be unpredictable. I would add postop RT for very close margins. PNI would depend on extent of nerve involvement. I would if it was extensive. I would not for LVSI. I would in the unlikely event of positive nodes.